Oncotarget

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/03/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Advance Publications: Research Papers:

Enteric coated mycophenolate sodium combined with lowdose steroid as first line therapy in minimal change nephrotic syndrome: an open label randomized controlled study

Maggie K.M. Ma _, Desmond Y.H. Yap, Chiu Leung Li, Maggie M.Y. Mok, Gary C.W. Chan, Lorraine P.Y. Kwan, Kar Neng Lai and Sydney C.W. Tang

 

Maggie K.M. Ma1, Desmond Y.H. Yap1, Chiu Leung Li2, Maggie M.Y. Mok1, Gary C.W. Chan1, Lorraine P.Y. Kwan1, Kar Neng Lai1 and Sydney C.W. Tang1

1Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China

2Renal Department, Centro Hospitalar Conde de São Januário, Macao, China

Correspondence to:

Sydney C.W. Tang, email: [email protected]

Keywords: nephropathy; mycophenolate; minimal change disease

Received: August 21, 2017     Accepted: December 03, 2017     Published: January 03, 2018


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23838